drugset / Trial / NCT04392739
Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG
Phase 4
Completed
34 enrolled
SIGA Technologies
Biomedical Advanced Research and Development Authority · collabPPD Development, LP · collab
NaSingle-groupOpen-labelOther
Summary
Safety and PK study in adults weighing more than 120 kg
Timeline
- Start
- 2019-07-19
- Primary completion
- 2019-12-05
- Completion
- 2019-12-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tecovirimat | Small molecule | 600 mg | Oral |